Search alternatives:
we decrease » _ decrease (Expand Search), nn decrease (Expand Search), teer decrease (Expand Search)
m decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
12 m » 12 mm (Expand Search), 12 mg (Expand Search), 12 _ (Expand Search)
we decrease » _ decrease (Expand Search), nn decrease (Expand Search), teer decrease (Expand Search)
m decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
12 m » 12 mm (Expand Search), 12 mg (Expand Search), 12 _ (Expand Search)
-
100881
-
100882
-
100883
-
100884
-
100885
-
100886
-
100887
-
100888
-
100889
-
100890
-
100891
DataSheet_1_Coexpression of HHLA2 and PD-L1 on Tumor Cells Independently Predicts the Survival of Spinal Chordoma Patients.docx
Published 2023“…</p>Methods<p>Using multiplexed quantitative immunofluorescence (QIF), we simultaneously measured the levels of five different immune checkpoint molecules and major TIL subsets in 92 human spinal chordoma samples.…”
-
100892
DataSheet_1_Coexpression of HHLA2 and PD-L1 on Tumor Cells Independently Predicts the Survival of Spinal Chordoma Patients.docx
Published 2022“…</p>Methods<p>Using multiplexed quantitative immunofluorescence (QIF), we simultaneously measured the levels of five different immune checkpoint molecules and major TIL subsets in 92 human spinal chordoma samples.…”
-
100893
Image_1_Assessment of Sustainable Elimination Criteria for Iodine Deficiency Disorders Recommended by International Organizations.TIF
Published 2022“…The prevalence of thyroid disease in pregnant women had a sharp decreasing trend with increasing PHCAIS. …”
-
100894
Table3_Indications and adverse events of teriparatide: based on FDA adverse event reporting system (FAERS).DOCX
Published 2024“…For osteoporosis, main AEs were pain (18.2%), fractures (12.4%), muscle spasms (7.7%), and nausea (6.5%), while glucocorticoid-induced osteoporosis AEs included fractures (24.1%), pain (13.2%), decreased bone density (9.8%), and nausea (5.1%).…”
-
100895
<i>MEF2C</i> and <i>EPAS1</i> maintain muscle phenotype and glucose homeostasis in chronic hypoxia.
Published 2020“…(E) SDH of muscle showed a reduction in fiber size in sparrows with downregulated <i>MEF2C</i> expression and high expression of <i>MEF2C</i> and <i>EPAS1</i>(n = 5 each). …”
-
100896
Table4_Indications and adverse events of teriparatide: based on FDA adverse event reporting system (FAERS).DOCX
Published 2024“…For osteoporosis, main AEs were pain (18.2%), fractures (12.4%), muscle spasms (7.7%), and nausea (6.5%), while glucocorticoid-induced osteoporosis AEs included fractures (24.1%), pain (13.2%), decreased bone density (9.8%), and nausea (5.1%).…”
-
100897
Table7_Indications and adverse events of teriparatide: based on FDA adverse event reporting system (FAERS).DOCX
Published 2024“…For osteoporosis, main AEs were pain (18.2%), fractures (12.4%), muscle spasms (7.7%), and nausea (6.5%), while glucocorticoid-induced osteoporosis AEs included fractures (24.1%), pain (13.2%), decreased bone density (9.8%), and nausea (5.1%).…”
-
100898
Table_2_Assessment of Sustainable Elimination Criteria for Iodine Deficiency Disorders Recommended by International Organizations.DOCX
Published 2022“…The prevalence of thyroid disease in pregnant women had a sharp decreasing trend with increasing PHCAIS. …”
-
100899
Table_1_Assessment of Sustainable Elimination Criteria for Iodine Deficiency Disorders Recommended by International Organizations.DOCX
Published 2022“…The prevalence of thyroid disease in pregnant women had a sharp decreasing trend with increasing PHCAIS. …”
-
100900
Table9_Indications and adverse events of teriparatide: based on FDA adverse event reporting system (FAERS).DOCX
Published 2024“…For osteoporosis, main AEs were pain (18.2%), fractures (12.4%), muscle spasms (7.7%), and nausea (6.5%), while glucocorticoid-induced osteoporosis AEs included fractures (24.1%), pain (13.2%), decreased bone density (9.8%), and nausea (5.1%).…”